Ibrahim Dighriri, Abdulrahman Hommadi, Hatim Zaeri, Rahaf Aldajany, Rahaf Alotaibi, Fai Aljuaid, Shoug Aljuaid, Abdullah Madkhali, Saleh Ghulaysi, Abeer Alanazi, Sarah Alburaidi, Amal Hamdan, Hassan Alzahrani, Razan Musharraf & Bashaier Albutaih·Journal of Pharmaceutical Research International·2021
Background: Atorvastatin is a recent HMG-COA reductase inhibitor used to treat primary hypercholesterolemia, homozygous familial hypercholesterolemia, and mixed dyslipidemias. It is also taken to prevent heart disease, including strokes and heart attacks. In addition, Atorvastati...
Open access
Research Article10.9734/jpri/2021/v33i54A33750
Ibrahim Dighriri, Ahmed Mobarki, Naif Althomali, Khalid Alqurashi, Othman Daghriri, Bashaer Bin Howimel, Izdihar Alahmad, Rawan Alsaadi, Manar Alsufyani, Manar Balobade, Reem Altemani, Bayader Alatawi, Wejdan Sharoufna, Taif Almuntashiri & Sultan Almushawwah·Journal of Pharmaceutical Research International·2021
Introduction: Metronidazole has been prescribed to treat infections for over a century and continues to be helpful in the therapy of amoebiasis, trichomoniasis, and giardiasis. Metronidazole is a cost-effective medication because of its low price, few adverse effects, and favorab...
Open access
Research Article10.9734/jpri/2021/v33i47A33049
Khaled Alhusayni, Ibrahim Dighriri, Abdullah Althomali, Abdulaziz Alkhammash, Faisal Alharthi, Adel Alharthi, Theaar Alotaibi, Saeed Alzahrani, Abdulrahman Hommadi, Fahad Rajab, Majed Alfaifi, Ibrahim Mobarki, Sultan Alrubaiei, Rasha Alqahtani & Shaden Bin Howimel·Journal of Pharmaceutical Research International·2021
Introduction: Patients admitted to the hospital will receive various drugs, each carrying the risk of error. Medication errors concern our healthcare system, especially considering the relatively high number of patients admitted to hospitals. Assuming that each patient receives a...
Open access
Research Article10.9734/jpri/2021/v33i51A33466
Abdulmajeed Albalawi, Ibrahim Dighriri, Ahad Alsharif, Emtenan Basahl, Fatimah Alrajab, Shuruq Alzahuf, Bashair Alharbi, Khaled Alahmadi, Husam Alkhathlan, Sarah Alharbi, Amjad Aljubairy, Jana Babaqi, Bader Alotaibi, Asma Mrair & Turki Alhujuri·Journal of Pharmaceutical Research International·2021
Background: Calciphylaxis, also known as calcific uremic arteriolopathy, is a well-described condition in renal transplant and end-stage kidney disease (ESKD) patients; however, little is known about calciphylaxis induced by nonuremic causes. This systematic study aimed to determ...
Open access
Research Article10.9734/jpri/2021/v33i39B32192